Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1092, 489-498
Abstract
No abstract availableKeywords
Funding Information
- Cairo University (IRG 2015–003)
This publication has 40 references indexed in Scilit:
- Solid phase extraction liquid chromatography mass spectrometry method with electrospray ionization for the determination of Ondansetron in human plasma: Development and validation considerationArabian Journal of Chemistry, 2017
- Influence of different proton pump inhibitors on the pharmacokinetics of voriconazoleInternational Journal of Antimicrobial Agents, 2017
- Simultaneous determination of 200 pesticide residues in honey using gas chromatography–tandem mass spectrometry in conjunction with streamlined quantification approachJournal of Chromatography A, 2016
- Determination of Voriconazole Concentrations in Serum by GC‐MSJournal of Clinical Laboratory Analysis, 2015
- Plasma Voriconazole Estimation by HPLCIndian Journal of Clinical Biochemistry, 2015
- Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approachAnnals of Hematology, 2015
- Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patientsInternational Journal of Clinical Pharmacy, 2014
- Development and validation of a sensitive and high‐throughput LC‐MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasmaBiomedical Chromatography, 2013
- Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipientsPediatric Blood & Cancer, 2012
- Fast and simple LC–MS/MS method for quantifying plasma voriconazoleClinica Chimica Acta, 2012